-
ATTO share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ATTO stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ATTO market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
About ATTO
Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing next-generation biotherapeutics for immune-mediated diseases. It delivers treatments through its platform, ATTOBODY. The company was founded by Tao Fu, Zaneta Odrowaz, and Petter Veiby on December 16, 2022 and is headquartered in San Carlos, CA.
-
ATTO market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
Smart score
Latest ATTO news
No recent TipRanks articles are available for ATTO
No recent press releases are available for ATTO
ATTO Financials
-
ATTO total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
ATTO net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
ATTO earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
ATTO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ATTO Competitors
-
How competitors are chosen
ATTO's competitors are included in the Health Technology sector and Biotechnology group
-
ATTO market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.
